I-NSAID - Into Okumele Uyazi

I-NSAID ziphakathi kwezidakamizwa eziqhelekileyo eziqhelekileyo

I-NSAID (izidakamizwa ezichasene ne-antisteroidal anti-inflammatory) zilwa ne-arthritis ngokuphazamisa inkqubo yokuvuvukala. Ii-NSAID ziqela elikhulu lamachiza esetyenziswa ngokubanzi ekuphatheni i-arthritis ngenxa yabo:

NSAID I ziqendu

Kukho iintlobo ezintathu ze-NSAID:

Ii-NSAID ezisetyenziswa rhoqo kwi-arthritis ziquka:

Indlela i-NSAID isebenza ngayo

Ngendlela elula, ii-NSAID zisebenza ngokunciphisa ukuvuvukala. Benza oku ngokuthintela i-enzyme eyintloko ye-inflammation ebizwa nge-cyclooxygenase, eguqula i-arachidonic acid kwi-prostaglandins kunye ne-leukotrienes.

Iprostaglandins yenza ukuba ukutshaya kwendawo. Ngoko ke, ngokuvimbela i-cyclooxygenase, ii-NSAID zinciphisa ukuvuvukala .

I-NSAID ethile inokusebenza kangcono kuwe kunokuba wazama ngaphambili - okanye ayikwazi ukusebenza nhlobo. Kungenxa yento ebizwa ngokuba yi-apmmacokinetic difference - inkqubo eyenziwa ngayo isilwanyana, isasazwa, isetyenziswe, kwaye isuswe.

Oku ngakumbi kwi-Enzyme Cyclooxygenase

Kukho iindlela ezimbini ze-cyclooxygenase, ezaziwa njenge-COX-1 kunye ne-COX-2. I-COX-1 ibandakanyeka ekugcineni isisu esisempilo kunye nezifo zengqondo. I-COX-2 yi-enzyme ejongene nokuvuvukala. Ngenxa yokuba i-NSAID yendabuko ivimba zombini i-COX-1 kunye ne-COX-2, ingaba nemiphumo engathandekiyo, efana nesisu okanye isifo sezintso esinciphile. Yingakho abaphandi bavelisa i-NSAIDS ekhusela i-COX-2 kuphela. Ezi i-COX-2 inhibitors ezikhethiweyo yiqela elitsha lama-NSAID.

Iimpawu ze-FDA kuzo zonke i-NSAID

Ngo-2004, umenzi we-COX-2 inhibitor ekhethekileyo u-Vioxx wayezikhethile ngokuzenzekelayo emakethe emva kokuba uphando lubonakalise ukusetyenziswa kwexesha elide kunokunyusa umngcipheko wokuhlaselwa kwintliziyo kunye nesifo. Ukuhlaziywa okulandelelweyo yi-US Food Administration and Drug Administration kwakhokelela kumfuno ka-2005 yokuba zonke ii-non-aspirin ze-NSAID zithatha isilumkiso esichaphazelekayo.

Kubalulekile ukuxoxa ngezi ngozi ezinokuthi ugqirha wakho. (Emva kokushiya enye i-COX-2 inhibitor kwimarike - iCelebrex.)

Ukusebenza kweeNSAID

Ngaphantsi

Akukwazi ukuqikelela ukuba yiyiphi enye iNSAID eya kukulungele ukukhonza. Akukho-NSAID enye ibonakaliswe ukuba iphakamileyo ngaphezu kwabanye ngenxa yosizi lwentlungu. Emva kokuba i-NSAID ikhethiwe, i-dosage kufuneka yinyuswe de ibe intlungu ikhutshwe okanye ide ifikelele kwiqondo elithintekayo. Impendulo yesigulane kufuneka ibe sisikhokelo sokukhetha i-dose efanelekileyo, usebenzisa i-dose ephantsi kakhulu ukufumana ukukhululeka kwentlungu. Qhubeka uxubusha iingenelo kunye nobungozi obunokwenzeka be-NSAID kunye nogqirha wakho.

> Imithombo:

> I-Duke University Medical Centre yeArthritis, uDavid S. Pisetsky, MD, Ph.D. 1995.

> I-New England Journal of Medicine, 324 (24): 1716-1725, 1991